Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001554795-15-000068
Filing Date
2015-02-20
Accepted
2015-02-20 14:27:09
Documents
10
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K skin0218form10k.htm 10-K 278804
2 EXHIBIT 31.1 skin0218form10kexh31_1.htm EX-31.1 7435
3 EXHIBIT 31.2 skin0218form10kexh31_2.htm EX-31.2 7351
4 EXHIBIT 32.1 skin0218form10kexh32_1.htm EX-32.1 3916
  Complete submission text file 0001554795-15-000068.txt   1490083

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE skin-20141231.xml EX-101.INS 114476
6 XBRL SCHEMA FILE skin-20141231.xsd EX-101.SCH 13047
7 XBRL CALCULATION FILE skin-20141231_cal.xml EX-101.CAL 22873
8 XBRL DEFINITION FILE skin-20141231_def.xml EX-101.DEF 14945
9 XBRL LABEL FILE skin-20141231_lab.xml EX-101.LAB 100882
10 XBRL PRESENTATION FILE skin-20141231_pre.xml EX-101.PRE 78083
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30991 | Film No.: 15635096
SIC: 6770 Blank Checks